Form 8-K - Current report:
SEC Accession No. 0001829126-22-016110
Filing Date
2022-08-23
Accepted
2022-08-23 16:51:30
Documents
33
Period of Report
2022-08-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K organicellregenra_8k.htm   iXBRL 8-K 81937
2 EXHIBIT 3.1 organicellregenra_ex3-1.htm EX-3.1 33662
3 EXHIBIT 3.2 organicellregenra_ex3-2.htm EX-3.2 245644
4 EXHIBIT 10.1 organicellregenra_ex10-1.htm EX-10.1 124495
5 EXHIBIT 10.2 organicellregenra_ex10-2.htm EX-10.2 123834
6 EXHIBIT 10.3 organicellregenra_ex10-3.htm EX-10.3 120458
7 EXHIBIT 10.4 organicellregenra_ex10-4.htm EX-10.4 117295
8 EXHIBIT 10.5 organicellregenra_ex10-5.htm EX-10.5 43682
9 EXHIBIT 10.6 organicellregenra_ex10-6.htm EX-10.6 41574
10 EXHIBIT 10.7 organicellregenra_ex10-7.htm EX-10.7 77459
11 EXHIBIT 10.8 organicellregenra_ex10-8.htm EX-10.8 77439
12 EXHIBIT 10.9 organicellregenra_ex10-9.htm EX-10.9 14767
13 EXHIBIT 10.10 organicellregenra_ex10-10.htm EX-10.10 16508
14 EXHIBIT 10.11 organicellregenra_ex10-11.htm EX-10.11 15009
15 EXHIBIT 10.12 organicellregenra_ex10-12.htm EX-10.12 12936
16 EXHIBIT 10.13 organicellregenra_ex10-13.htm EX-10.13 88009
17 EXHIBIT 10.14 organicellregenra_ex10-14.htm EX-10.14 1324
21 GRAPHIC ex3-1_001.jpg GRAPHIC 705010
22 GRAPHIC ex3-1_002.jpg GRAPHIC 1080097
23 GRAPHIC ex3-1_003.jpg GRAPHIC 69964
24 GRAPHIC ex10-14_001.jpg GRAPHIC 485043
25 GRAPHIC ex10-14_002aaaa.jpg GRAPHIC 91510
  Complete submission text file 0001829126-22-016110.txt   4950625

Data Files

Seq Description Document Type Size
18 XBRL SCHEMA FILE bpsr-20220819.xsd EX-101.SCH 2965
19 XBRL LABEL FILE bpsr-20220819_lab.xml EX-101.LAB 34240
20 XBRL PRESENTATION FILE bpsr-20220819_pre.xml EX-101.PRE 22363
27 EXTRACTED XBRL INSTANCE DOCUMENT organicellregenra_8k_htm.xml XML 3416
Mailing Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140
Business Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

EIN.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-55008 | Film No.: 221188121
SIC: 3790 Miscellaneous Transportation Equipment